Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-10

Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the safety of intravenous cultured allogeneic umbilical cord-derived mesenchymal stem cells for inflammatory bowel disease; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cultured allogeneic umbilical cord-derived mesenchymal stem cell infusion (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Inflammatory Bowel Diseases | Phase 1 | Status: RECRUITING